Argus Research Upgrades Elevance Health to Buy
Argus Research has upgraded its rating on Elevance Health from "Hold" to "Buy."
Stocks · News reference
The Elevance Health Foundation and Healthy Birth Day, Inc. have expanded their partnership to implement stillbirth prevention initiatives across 11 states.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Argus Research has upgraded its rating on Elevance Health from "Hold" to "Buy."
Catherine Gaffigan, President of Health Solutions at Elevance Health, has been named to the 2027 National Clinical Advisory Board of Monogram Health.
Elevance Health commissioned a national survey with The Harris Poll, revealing consumer perspectives on the role of artificial intelligence in simplifying healthcare information.
AM Best has assigned indicative Long-Term Issue Credit Ratings to Elevance Health, Inc.'s recently filed shelf registrations.
An Elevance Health executive indicated at the UBS Healthcare Conference that the company plans to more actively evaluate selective mergers and acquisitions starting in 2027.
Cantor Fitzgerald has updated its price target for Elevance Health, raising it from $450 to $493.